Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
This combination peptide supports growth hormone release with a strong focus on reducing visceral (belly) fat. Tesamorelin targets deep abdominal fat stores, while Ipamorelin supports steady GH signaling for better metabolism, recovery, and body composition. Together, they offer a powerful approach to midsection fat reduction and metabolic health. Administered subcutaneously, this blend is ideal for patients seeking targeted, impactful fat-loss support.
This combination peptide supports growth hormone release with a strong focus on reducing visceral (belly) fat. Tesamorelin targets deep abdominal fat stores, while Ipamorelin supports steady GH signaling for better metabolism, recovery, and body composition. Together, they offer a powerful approach to midsection fat reduction and metabolic health. Administered subcutaneously, this blend is ideal for patients seeking targeted, impactful fat-loss support.